Inventiva (IVA) Equity Average (2019 - 2025)
Inventiva (IVA) recorded quarterly Equity Average of -$5.1 billion in Q4 2025, up 0.79% quarter-over-quarter from -$5.1 billion in Q2 2025, and down 104.66% on a YoY basis from $108.6 billion in Q4 2024.
Inventiva (IVA) Equity Average (2019 - 2025) Analysis & Trends
Inventiva's Equity Average history runs 5 years deep, the most recent figure standing at -$5.1 billion for Q4 2025.
- In Q4 2025, Equity Average fell 104.66% year-over-year to -$5.1 billion; the TTM figure through Dec 2025 stood at -$5.1 billion (down 104.66% YoY), while the FY2025 annual figure was -$73.6 million, up 0.85% from the prior year.
- Equity Average was -$5.1 billion for Q4 2025 at Inventiva, up from -$5.1 billion in the prior quarter.
- In the past five years, Equity Average ranged from a high of $108.7 billion in Q2 2024 to a low of -$5.1 billion in Q2 2025.
- Historically, Equity Average has averaged $49.6 billion across 4 years, with a median of $47.4 billion in 2021.
- The sharpest annual moves came in 2024 and 2025: Equity Average soared 2192522.94% in 2024, then plunged 104.69% in 2025.
- A 4-year view of Equity Average shows it stood at $128.0 million in 2021, then plunged by 103.87% to -$5.0 million in 2023, then jumped by 2192522.94% to $108.6 billion in 2024, then tumbled by 104.66% to -$5.1 billion in 2025.
- The last three Equity Average figures came in at -$5.1 billion (Q4 2025), -$5.1 billion (Q2 2025), and $108.6 billion (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | 3.50 Bn |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | 783.14 Mn |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 3.76 Mn |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 1.01 Bn |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 21.35 Mn |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 19.01 Bn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | 516.41 Mn |
| 10 | Inventiva | 8.93 Mn | -259.80 Mn | - | -5.06 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.06 Bn |
| Jun 30, 2025 | -5.10 Bn |
| Dec 31, 2024 | 108.63 Bn |
| Jun 30, 2024 | 108.67 Bn |
| Dec 31, 2023 | -4.95 Mn |
| Oct 11, 2023 | 94.69 Bn |
| Jun 30, 2023 | 94.70 Bn |
| Mar 31, 2021 | 127.97 Mn |
| Dec 31, 2019 | 58.06 Mn |